Mark J. Shlomchik

Active 1986–2025

138
Papers
30,148
Citations
95
h-index
134
i10-index

Citations

Citations per year for Mark J. Shlomchik1982: 1 citations1987: 10 citations1988: 19 citations1989: 32 citations1990: 27 citations1991: 36 citations1992: 38 citations1993: 27 citations1994: 24 citations1995: 45 citations1996: 13 citations1997: 14 citations1998: 38 citations1999: 46 citations2000: 45 citations2001: 73 citations2002: 108 citations2003: 171 citations2004: 240 citations2005: 250 citations2006: 318 citations2007: 352 citations2008: 374 citations2009: 412 citations2010: 459 citations2011: 360 citations2012: 389 citations2013: 353 citations2014: 271 citations2015: 360 citations2016: 277 citations2017: 328 citations2018: 315 citations2019: 948 citations2020: 906 citations2021: 969 citations2022: 760 citations2023: 546 citations2024: 898 citations2025: 462 citations2026: 18 citations1983–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,912 citing papers, 35.8% of this breakdownChina: 892 citing papers, 8.2% of this breakdownGermany: 793 citing papers, 7.2% of this breakdownUnited Kingdom: 737 citing papers, 6.7% of this breakdownFrance: 486 citing papers, 4.4% of this breakdownJapan: 485 citing papers, 4.4% of this breakdownAustralia: 378 citing papers, 3.5% of this breakdownItaly: 299 citing papers, 2.7% of this breakdownCanada: 285 citing papers, 2.6% of this breakdownSwitzerland: 261 citing papers, 2.4% of this breakdownNetherlands: 247 citing papers, 2.3% of this breakdownSweden: 179 citing papers, 1.6% of this breakdown
0%35.8%Other 18.2%

Fields

  • Immunology and Microbiology46.7%
  • Medicine39.4%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences0.5%
  • Nursing0.2%
  • Other1%

Topics

  • T-cell and B-cell Immunology14.2%
  • Immune Cell Function and Interaction11.6%
  • Immunotherapy and Immune Responses7.3%
  • Immune Response and Inflammation4.2%
  • Systemic Lupus Erythematosus Research3.8%
  • Monoclonal and Polyclonal Antibodies Research3.5%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity

    Authors: , - Immunity 2020 cited by 514

  2. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis

    Authors: , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 269

  3. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype

    Authors: , , , , , , , - Nature Immunology 2014 cited by 443

  4. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 475

  5. Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of Lupus

    Authors: , , , , , - Immunity 2006 cited by 1,077

  6. A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells

    Authors: , , , - Immunity 2016 cited by 538

  7. B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells

    Authors: , , - Immunity 2018 cited by 324

  8. Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2023 cited by 120

  9. Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells

    Authors: , , , , , - Immunity 2017 cited by 270

  10. Surface phenotypes of naive and memory B cells in mouse and human tissues

    Authors: , , , , , , , , , - Nature Immunology 2021 cited by 114

  11. Memory B Cells of Mice and Humans

    Authors: , - Annual Review of Immunology 2017 cited by 304

  12. Comprehensive analyses of B-cell compartments across the human body reveal novel subsets and a gut-resident memory phenotype

    Authors: , , , , , , , - Blood 2020 cited by 125

  13. PIRs mediate innate myeloid cell memory to nonself MHC molecules

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2020 cited by 152

  14. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 804

  15. Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers

    Authors: , , , - Science 2002 cited by 561

  16. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

    Authors: , , , , , - Nature 2002 cited by 1,911

  17. MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 415

  18. Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation

    Authors: , , , , , , , , , , , , - Immunity 2015 cited by 226

  19. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus

    Authors: , , , , , , , , , , , , , , - Nature Immunology 2022 cited by 66

  20. IL-21R signal reprogramming cooperates with CD40 and BCR signals to select and differentiate germinal center B cells

    Authors: , , , , , , , , - Science Immunology 2023 cited by 79

  21. B cell–intrinsic TLR9 expression is protective in murine lupus

    Authors: , , , , , , , - Journal of Clinical Investigation 2020 cited by 97

  22. B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice

    Authors: , , , , , - JCI Insight 2023 cited by 48

  23. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

    Authors: , , , , , - Nature Immunology 2010 cited by 659

  24. The Type II Anti‐CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model

    Authors: , , , , , , , , , - Arthritis & Rheumatology 2020 cited by 67